跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Iritero - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Iritero
Approved
STANDARD
Iritero
Hetero Labs Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
cdc1a3efdb04dd1a
Company
Hetero Labs Limited
Type
Standard
Approval Details
Approval Id
cdc1a3efdb04dd1a
Drug Approval Philippines Name
Iritero
Product Name
Iritero
Registration Number
DRP-8210
Brand Name
Iritero
Generic Name
Irinotecan (as hydrochloride)
Dosage Form
Solution for Intravenous Infusion
Dosage Strength
40mg/ 2mL
Manufacturer
Hetero Labs Limited
Importer
S.M.H.P. Marketing & Consultancy
Distributor
S.M.H.P. Marketing & Consultancy
Company Detail Path
/organization/hetero-labs-limited
Issuance Date
24 January 2024
Expiry Date
31 May 2029
Pharmacologic Category
Antineoplastic (Cell Cycle-Specific Agent)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
cdc1a3efdb04dd1a
Type
Standard
Back to Philippines FDA Approvals